JAK2 and neoplasm: For example, a 2013 study showed that the inhibition of JAK2 using TG101209 and the inhibition of both JAK1 and JAK2 with INCB18424 in leukemic mice substantially decrease tumor size and improve survival outcomes, which are antecedents of the acquisition of genetic alterations [91].